Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 13, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Pacific biomarkers, inc.

Mario R Ehlers1

  • 1Pacific Biomarkers, Inc., 220 West Harrison Street, Seattle, WA 98119, USA. marioe@pacbio.com.

Biomarkers in Medicine
|May 19, 2010
PubMed
Summary

Pacific Biomarkers offers specialized biomarker testing for drug development. Services include ligand-binding assays, multiplexing, and immunogenicity testing within a compliant framework.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Pharmacological reviews·2019
Same author

Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.

Pediatric diabetes·2018
Same author

Who let the dogs out? The ever-present threat of autoreactive T cells.

Science immunology·2018
Same author

Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy.

Oncotarget·2018
Same author

Anti-Gal and Anti-Neu5Gc Responses in Nonimmunosuppressed Patients After Treatment With Rabbit Antithymocyte Polyclonal IgGs.

Transplantation·2017
Same author

Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.

Clinical therapeutics·2016

Area of Science:

  • Biotechnology
  • Clinical Diagnostics
  • Pharmaceutical Research

Background:

  • Pacific Biometrics, Inc. (PBI) is a specialty laboratory focused on clinical trials.
  • A new subsidiary, Pacific Biomarkers, Inc., has been established.
  • There is a growing need for specialized biomarker testing in drug development.

Purpose of the Study:

  • To establish a dedicated entity for biomarker testing services.
  • To support the clinical drug development pipeline.
  • To offer services in a regulatory-compliant environment.

Main Methods:

  • Ligand-binding assays (LBAs)
  • Multiplexing techniques
  • Immunogenicity testing assays

Main Results:

  • Establishment of Pacific Biomarkers, Inc. as a subsidiary of PBI.
  • Focus on specialized biomarker testing services.
  • Commitment to regulatory compliance in testing.

Conclusions:

  • Pacific Biomarkers is positioned to serve the needs of clinical drug development.
  • The company offers specialized assays crucial for evaluating drug efficacy and safety.
  • Operations will adhere to stringent regulatory standards for reliable results.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Western Blotting: Sample Preparation to Detection
07:45

Western Blotting: Sample Preparation to Detection

Published on: October 14, 2010

Related Experiment Videos

Last Updated: Jun 13, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Western Blotting: Sample Preparation to Detection
07:45

Western Blotting: Sample Preparation to Detection

Published on: October 14, 2010